Study Summary
This trial is testing whether a flow diverter, a new device used to treat intracranial aneurysms, is effective and has an acceptable rate of complications.
- Brain Aneurysm
Treatment Effectiveness
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: discharge, 3 and 12 months
Trial Safety
Trial Design
2 Treatment Groups
flow diversion
1 of 2
Best standard treatment
1 of 2
Active Control
344 Total Participants · 2 Treatment Groups
Primary Treatment: flow diversion · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 75 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Raymond, Jean, Jean-Christophe Gentric, Tim E. Darsaut, Daniela Iancu, Miguel Chagnon, Alain Weill, and Daniel Roy. 2017. “Flow Diversion in the Treatment of Aneurysms: A Randomized Care Trial and Registry”. Journal of Neurosurgery. Journal of Neurosurgery Publishing Group (JNSPG). doi:10.3171/2016.4.jns152662.
- 2011. "Flow Diversion in Intracranial Aneurysm Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01349582.
Frequently Asked Questions
Is it possible to participate in this medical experiment?
"This trial is prospectively enrolling 344 individuals between the ages of 18 and 75 who suffer from berry aneurysm. In order to meet inclusion criteria, patients must have a "difficult" intracranial aneurysm in which flow diversion can be seen as a suitable or best option for treatment by their clinician. These conditions may include symptomatic large or giant cavernous carotid, ophthalmic and vertebral aneurysms, fusiform intradural aneurysms, or recurring lesions that have not been addressed through coiling procedures previously. Moreover, this clinical trial will rarely accept" - Anonymous Online Contributor
How many individuals have signed up to take part in this experiment?
"Affirmative. Based on the information provided by clinicaltrials.gov, this medical trial is presently recruiting patients. It was first posted on May 2nd 2011 and most recently updated July 19th 2022. The study necessitates 344 participants from 3 separate locations to be recruited." - Anonymous Online Contributor
Is enrollment for this study still open?
"Clinicaltrials.gov shows that since it's initial posting on May 2nd 2011, this trial is presently seeking participants and was recently updated on July 19th 2022." - Anonymous Online Contributor
Is this study welcoming participants who are of legal age?
"This study requires that potential participants are of legal age and have not yet reached their 75th birthday." - Anonymous Online Contributor